Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chi

Showing results (671-680 of 903) with videos related to

Pageof 91
Sort By:
Gynecologic Oncology|March 14, 2017
A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancerRenee A Cowan, Ane Gerda Zahl Eriksson, Sara M Jaber, et al.
Gynecologic Oncology|December 22, 2009
A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer careN R Abu-Rustum, Q Zhou, J D Gomez, et al.
Gynecologic Oncology|September 26, 2006
CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapyMargrit M Juretzka, Richard R Barakat, Dennis S Chi, et al.
Pediatric Cardiology|August 26, 2006
Comparison of heart failure in children with enterovirus 71 rhombencephalitis and cats with norepinephrine cardiotoxicityY-C Fu, C-S Chi, N-N Lin, et al.
Gynecologic Oncology|December 23, 2008
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinomaDennis S Chi, Oliver Zivanovic, Meena J Palayekar, et al.
Gynecologic Oncology|August 12, 2009
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancerOliver Zivanovic, Camelia S Sima, Alexia Iasonos, et al.
Gynecologic Oncology|September 11, 2013
Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidityKara C Long, Edward J Tanner, Melissa Frey, et al.
International Journal of Cancer|August 13, 2017
Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma modelsShinichi Esaki, Fares Nigim, Esther Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed GlioblastomaJaishri O Blakeley, Stuart A Grossman, Andrew S Chi, et al.
Gynecologic Oncology|March 28, 2021
Frailty based on the memorial Sloan Kettering Frailty Index is associated with surgical decision making, clinical trial participation, and overall survival among older women with ovarian cancerOlga T Filippova, Amy L Tin, Joanne Alonso, et al.
Pageof 91

Showing results (671-680 of 903) with videos related to

Sort By:
Pageof 91
Gynecologic Oncology|March 14, 2017
A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancerRenee A Cowan, Ane Gerda Zahl Eriksson, Sara M Jaber, et al.
Gynecologic Oncology|December 22, 2009
A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer careN R Abu-Rustum, Q Zhou, J D Gomez, et al.
Gynecologic Oncology|September 26, 2006
CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapyMargrit M Juretzka, Richard R Barakat, Dennis S Chi, et al.
Pediatric Cardiology|August 26, 2006
Comparison of heart failure in children with enterovirus 71 rhombencephalitis and cats with norepinephrine cardiotoxicityY-C Fu, C-S Chi, N-N Lin, et al.
Gynecologic Oncology|December 23, 2008
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinomaDennis S Chi, Oliver Zivanovic, Meena J Palayekar, et al.
Gynecologic Oncology|August 12, 2009
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancerOliver Zivanovic, Camelia S Sima, Alexia Iasonos, et al.
Gynecologic Oncology|September 11, 2013
Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidityKara C Long, Edward J Tanner, Melissa Frey, et al.
International Journal of Cancer|August 13, 2017
Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma modelsShinichi Esaki, Fares Nigim, Esther Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed GlioblastomaJaishri O Blakeley, Stuart A Grossman, Andrew S Chi, et al.
Gynecologic Oncology|March 28, 2021
Frailty based on the memorial Sloan Kettering Frailty Index is associated with surgical decision making, clinical trial participation, and overall survival among older women with ovarian cancerOlga T Filippova, Amy L Tin, Joanne Alonso, et al.
Pageof 91